vs
CHOICEONE FINANCIAL SERVICES INC（COFS）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
CHOICEONE FINANCIAL SERVICES INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍（$42.9M vs $35.5M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 76.4%），CHOICEONE FINANCIAL SERVICES INC自由现金流更多（$25.2M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 15.0%）
ChoiceOne Financial Services Inc是一家美国区域金融控股公司，通过旗下银行子公司开展业务，主要为密歇根州的个人消费者、小微企业及企业客户提供储蓄账户、贷款、财富管理、保险等多元化个人及商业银行服务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
COFS vs RXRX — 直观对比
营收规模更大
COFS
是对方的1.2倍
$35.5M
营收增速更快
RXRX
高出605.4%
76.4%
自由现金流更多
COFS
多$72.5M
$-47.3M
两年增速更快
RXRX
近两年复合增速
15.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $42.9M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 39.1% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 76.4% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $1.43 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COFSRXRX
| Q4 25 | $42.9M | $35.5M | ||
| Q3 25 | $61.8M | $5.2M | ||
| Q2 25 | $60.4M | $19.2M | ||
| Q1 25 | $44.9M | $14.7M | ||
| Q4 24 | $24.3M | $4.5M | ||
| Q3 24 | $36.6M | $26.1M | ||
| Q2 24 | $34.0M | $14.4M | ||
| Q1 24 | $32.5M | $13.8M |
净利润COFSRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $14.7M | $-162.3M | ||
| Q2 25 | $13.5M | $-171.9M | ||
| Q1 25 | $-13.9M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $7.3M | $-95.8M | ||
| Q2 24 | $6.6M | $-97.5M | ||
| Q1 24 | $5.6M | $-91.4M |
毛利率COFSRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率COFSRXRX
| Q4 25 | 39.1% | -304.8% | ||
| Q3 25 | 29.6% | -3327.6% | ||
| Q2 25 | 27.6% | -916.8% | ||
| Q1 25 | -39.2% | -1297.9% | ||
| Q4 24 | 36.1% | -4042.4% | ||
| Q3 24 | 25.4% | -377.1% | ||
| Q2 24 | 24.0% | -697.4% | ||
| Q1 24 | 21.1% | -698.4% |
净利率COFSRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | 23.7% | -3135.3% | ||
| Q2 25 | 22.4% | -894.2% | ||
| Q1 25 | -31.0% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 20.1% | -367.5% | ||
| Q2 24 | 19.4% | -676.6% | ||
| Q1 24 | 17.3% | -662.4% |
每股收益（稀释后）COFSRXRX
| Q4 25 | $1.43 | $-0.17 | ||
| Q3 25 | $0.97 | $-0.36 | ||
| Q2 25 | $0.90 | $-0.41 | ||
| Q1 25 | $-1.29 | $-0.50 | ||
| Q4 24 | $0.79 | $-0.56 | ||
| Q3 24 | $0.85 | $-0.34 | ||
| Q2 24 | $0.87 | $-0.40 | ||
| Q1 24 | $0.74 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $88.0M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $465.4M | $1.1B |
| 总资产 | $4.4B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资COFSRXRX
| Q4 25 | $88.0M | $743.3M | ||
| Q3 25 | $99.0M | $659.8M | ||
| Q2 25 | $156.3M | $525.1M | ||
| Q1 25 | $139.4M | $500.5M | ||
| Q4 24 | $96.8M | $594.4M | ||
| Q3 24 | $145.9M | $427.6M | ||
| Q2 24 | $101.0M | $474.3M | ||
| Q1 24 | $150.1M | $296.3M |
总债务COFSRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益COFSRXRX
| Q4 25 | $465.4M | $1.1B | ||
| Q3 25 | $449.6M | $1.0B | ||
| Q2 25 | $431.8M | $919.1M | ||
| Q1 25 | $427.1M | $933.9M | ||
| Q4 24 | $260.4M | $1.0B | ||
| Q3 24 | $247.7M | $524.6M | ||
| Q2 24 | $214.5M | $584.4M | ||
| Q1 24 | $206.8M | $401.2M |
总资产COFSRXRX
| Q4 25 | $4.4B | $1.5B | ||
| Q3 25 | $4.3B | $1.4B | ||
| Q2 25 | $4.3B | $1.3B | ||
| Q1 25 | $4.3B | $1.3B | ||
| Q4 24 | $2.7B | $1.4B | ||
| Q3 24 | $2.7B | $726.5M | ||
| Q2 24 | $2.7B | $775.9M | ||
| Q1 24 | $2.7B | $557.8M |
负债/权益比COFSRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $25.2M | $-47.3M |
| 自由现金流率自由现金流/营收 | 58.7% | -133.1% |
| 资本支出强度资本支出/营收 | 15.4% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $38.5M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流COFSRXRX
| Q4 25 | $31.8M | $-46.1M | ||
| Q3 25 | $15.3M | $-117.4M | ||
| Q2 25 | $9.0M | $-76.4M | ||
| Q1 25 | $-6.5M | $-132.0M | ||
| Q4 24 | $47.1M | $-115.4M | ||
| Q3 24 | $-7.4M | $-59.2M | ||
| Q2 24 | $15.7M | $-82.2M | ||
| Q1 24 | $15.3M | $-102.3M |
自由现金流COFSRXRX
| Q4 25 | $25.2M | $-47.3M | ||
| Q3 25 | $13.7M | $-117.6M | ||
| Q2 25 | $6.9M | $-79.6M | ||
| Q1 25 | $-7.3M | $-133.8M | ||
| Q4 24 | $45.4M | $-116.7M | ||
| Q3 24 | $-7.6M | $-63.8M | ||
| Q2 24 | $15.3M | $-83.4M | ||
| Q1 24 | $15.0M | $-109.0M |
自由现金流率COFSRXRX
| Q4 25 | 58.7% | -133.1% | ||
| Q3 25 | 22.1% | -2272.5% | ||
| Q2 25 | 11.4% | -413.9% | ||
| Q1 25 | -16.3% | -907.4% | ||
| Q4 24 | 186.4% | -2567.7% | ||
| Q3 24 | -20.8% | -244.6% | ||
| Q2 24 | 44.8% | -578.5% | ||
| Q1 24 | 46.2% | -789.9% |
资本支出强度COFSRXRX
| Q4 25 | 15.4% | 3.5% | ||
| Q3 25 | 2.6% | 4.7% | ||
| Q2 25 | 3.4% | 16.4% | ||
| Q1 25 | 1.9% | 12.4% | ||
| Q4 24 | 7.0% | 28.6% | ||
| Q3 24 | 0.7% | 17.5% | ||
| Q2 24 | 1.4% | 8.2% | ||
| Q1 24 | 1.0% | 48.2% |
现金转化率COFSRXRX
| Q4 25 | — | — | ||
| Q3 25 | 1.04× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.00× | — | ||
| Q2 24 | 2.39× | — | ||
| Q1 24 | 2.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
